NMPA-approved traditional Chinese medicine-Pingwei Pill: new indication for colistin recovery against MCR-positive bacteria infection

• Autors principals: Qiushuang Sheng (Autor), Runbao Du (Autor), Cunhui Ma (Autor), Yonglin Zhou (Autor), Xue Shen (Autor), Xiaoning Hou (Autor), Lei Xu (Autor), Li Li (Autor), Xuming Deng (Autor), Jianfeng Wang (Autor)
• Format: Llibre
• Publicat: BMC, 2021-10-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Background The wide spread of plasmid-mediated colistin resistance by mobile colistin resistance (MCR) in Enterobacteriaceae severely limits the clinical application of colistin as a last-line drug against bacterial infection. The identification of colistin potentiator from natural plants o...